MEK inhibitors specifically target melanoma cells with elevated phospho-ERK

被引：0
|
作者：
Suzuki, H
Kolodney, MS
机构：
[1] LA BIOMED, Gen Internal Med, Torrance, CA USA
[2] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2005年 / 124卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
894
引用
收藏
页码：A149 / A149
页数：1
相关论文
共 50 条
  • [1] Phospho-ERK Expression As a Predictor of Therapeutic Response to MEK-1/2 Inhibitors in Biliary Tract Cancers
    South, Christopher D.
    Baker, Michael J.
    Phelps, Mitch A.
    Ringel, Mattew
    Patel, Tushar
    Bekaii-Saab, Tanios
    GASTROENTEROLOGY, 2009, 136 (05) : A858 - A858
  • [2] Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy
    K H T Paraiso
    I V Fedorenko
    L P Cantini
    A C Munko
    M Hall
    V K Sondak
    J L Messina
    K T Flaherty
    K S M Smalley
    British Journal of Cancer, 2010, 102 : 1724 - 1730
  • [3] Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy
    Paraiso, K. H. T.
    Fedorenko, I. V.
    Cantini, L. P.
    Munko, A. C.
    Hall, M.
    Sondak, V. K.
    Messina, J. L.
    Flaherty, K. T.
    Smalley, K. S. M.
    BRITISH JOURNAL OF CANCER, 2010, 102 (12) : 1724 - 1730
  • [4] MEK inhibition kills melanoma cells with constitutively elevated ERK activity
    Suzuki, H
    Iqbal, M
    Kolodney, MS
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A159 - A159
  • [5] Phospho-ERK staining is a poor indicator of the mutational status of BRAF and NRAS in human melanoma
    Houben, Roland
    Vetter-Kauczok, Claudia S.
    Ortmann, Sonja
    Rapp, Ulf R.
    Broecker, Eva B.
    Becker, Juergen C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 (08) : 2003 - 2012
  • [6] Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels
    Smalley, K. S. M.
    Contractor, R.
    Haass, N. K.
    Lee, J. T.
    Nathanson, K. L.
    Medina, C. A.
    Flaherty, K. T.
    Herlyn, M.
    BRITISH JOURNAL OF CANCER, 2007, 96 (03) : 445 - 449
  • [7] Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer
    Wang, Cun
    Jin, Haojie
    Gao, Dongmei
    Lieftink, Cor
    Evers, Bastiaan
    Jin, Guangzhi
    Xue, Zheng
    Wang, Liqin
    Beijersbergen, Roderick L.
    Qin, Wenxin
    Bernards, Rene
    JOURNAL OF HEPATOLOGY, 2018, 69 (05) : 1057 - 1065
  • [8] Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels
    K S M Smalley
    R Contractor
    N K Haass
    J T Lee
    K L Nathanson
    C A Medina
    K T Flaherty
    M Herlyn
    British Journal of Cancer, 2007, 96 : 445 - 449
  • [9] Lithium chloride inhibits the migration and invasion of osteosarcoma cells by blocking nuclear translocation of phospho-Erk
    Kim, Ju Yeong
    Park, Hun Hee
    Yong, Tai-Soon
    Jeon, Soung-Hoo
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 581 : 74 - 80
  • [10] Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma
    Carlino, Matteo S.
    Todd, Jason R.
    Gowrishankar, Kavitha
    Mijatov, Branka
    Pupo, Gulietta M.
    Fung, Carina
    Snoyman, Stephanie
    Hersey, Peter
    Long, Georgina V.
    Kefford, Richard F.
    Rizos, Helen
    MOLECULAR ONCOLOGY, 2014, 8 (03) : 544 - 554
12345